EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions

Igor Belenichev iD, Olena Popazova iD, Nina Bukhtiyarova iD, Victor Ryzhenko iD, Sergii Pavlov iD, Elina Suprun, Valentyn Oksenych iD, Oleksandr Kamyshnyi iD

Antioxidants · 18.01.2025 · 14 (1) · 108

DOI: 10.3390/antiox14010108 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 18.01.2025. Verfasst von Igor Belenichev und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Medical Formulation with Course of Normal Physiology, Zaporizhzhia State Medical and Pharmaceutical University, 69000 …. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 332 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study of mitochondrial dysfunction has become increasingly pivotal in elucidating the pathophysiology of various cerebral pathologies, particularly neurodegenerative disorders. Mitochondria are essential for cellular energy metabolism, regulation of reactive oxygen species (ROS), calcium homeostasis, and the execution of apoptotic processes. Disruptions in mitochondrial function, driven by factors such as oxidative stress, excitotoxicity, and altered ion balance, lead to neuronal death and contribute to cognitive impairments in several brain diseases. Mitochondrial dysfunction can arise from genetic mutations, ischemic events, hypoxia, and other environmental factors. This article highlights the critical role of mitochondrial dysfunction in the progression of neurodegenerative diseases and discusses the need for targeted therapeutic strategies to attenuate cellular damage, restore mitochondrial function, and enhance neuroprotection.

Schlagwörter

Stichwörter der Autor:innen

HIF-1HSP70ROScerebral ischemiamitochondrial dysfunction

Autor:innen und Institutionen

  • Department of Pharmacology and Medical Formulation with Course of Normal Physiology, Zaporizhzhia State Medical and Pharmaceutical University, 69000 Zaporizhzhia, Ukraine.
  • Department of Histology, Cytology and Embryology, Zaporizhzhia State Medical and Pharmaceutical University, 69000 Zaporizhzhia, Ukraine.
  • Department of Clinical Laboratory Diagnostics, Zaporizhzhia State Medical and Pharmaceutical University, 69000 Zaporizhzhia, Ukraine.
  • Department of Medical and Pharmaceutical Informatics and Advanced Technologies, Zaporizhzhia State Medical University, 69000 Zaporizhzhia, Ukraine.
  • The State Institute of Neurology, Psychiatry and Narcology of the National Academy of Medical Sciences of Ukraine, 46 Academician Pavlov Street, 61076 Kharkov, Ukraine.
  • Faculty of Medicine, University of Bergen, 5020 Bergen, Norway.

ORCID-Profile: Igor Belenichev, Olena Popazova, Nina Bukhtiyarova, Victor Ryzhenko, Sergii Pavlov, Valentyn Oksenych, Oleksandr Kamyshnyi

Zitieren

APA

Belenichev, I., Popazova, O., Bukhtiyarova, N., Ryzhenko, V., Pavlov, S., Suprun, E., Oksenych, V., & Kamyshnyi, O. (2025). Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions. Antioxidants, 14(1), 108. https://doi.org/10.3390/antiox14010108

Vancouver

Belenichev I, Popazova O, Bukhtiyarova N, Ryzhenko V, Pavlov S, Suprun E, et al. Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions. Antioxidants. 2025;14(1):108. doi:10.3390/antiox14010108

BibTeX
@article{Belenichev2025,
  author = {Belenichev, Igor and Popazova, Olena and Bukhtiyarova, Nina and Ryzhenko, Victor and Pavlov, Sergii and Suprun, Elina and Oksenych, Valentyn and Kamyshnyi, Oleksandr},
  title = {Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions},
  journal = {Antioxidants},
  year = {2025},
  volume = {14},
  number = {1},
  pages = {108},
  doi = {10.3390/antiox14010108}
}
Kostenlos starten →